OVARY CANCER

This early-stage trial tests whether a patient's own immune cells can be genetically modified to recognize and attack their cancer. The study is for adults with advanced cancers that have spread and express a specific marker called NY-ESO-1. Researchers will first find the safest…

This study is testing whether a combination of two drugs, mirvetuximab soravtansine and olaparib, can help keep cancer from growing back in women whose ovarian, peritoneal, or fallopian tube cancer has returned but initially responded well to platinum-based chemotherapy. The main…

This study is testing whether some ovarian cancer patients can safely skip getting a temporary stoma bag (an opening in the abdomen for waste) after major bowel surgery. Researchers want to see if carefully selected 'low-risk' patients heal just as well without this common proced…

This study is testing whether two drugs, Senaparib and Temozolomide, work together to shrink tumors in women with recurrent clear cell or endometrioid ovarian, fallopian tube, or primary peritoneal cancers that have a specific genetic change called an ARID1A mutation. The trial i…

This study is testing a new type of personalized cell therapy for adults with advanced solid tumors that have come back or spread. The therapy, called Tmod CAR T, is designed to recognize and kill cancer cells while using a built-in safety switch to protect the patient's healthy …

This study is testing whether drinking tart cherry juice can prevent nerve pain (neuropathy) caused by a common chemotherapy drug called paclitaxel. It will enroll 86 people with breast or ovarian cancer who are starting this type of chemo. Participants will be randomly assigned …

This study is testing whether showing educational videos to patients can increase how many people with ovarian or endometrial cancer get recommended genetic testing. Researchers will enroll 30 patients to watch a video and may ask them to complete a survey. They will then check m…